In TCGA, PMEPA1 correlated to poor prognosis in patients with lower T classification (Ta+T1+T2), lower M classification (M0), high grade (III), smoking, male patients, low immune infiltration levels of TME, and without lymph node metastasis (N0). Here, PMEPA1 is linked to metastatic malignant neoplasm in the lymph nodes.